QUOTE AND NEWS
Motley Fool  Jul 26  Comment 
Find out what's behind the big gains for these companies.
MarketWatch  Jul 11  Comment 
Arena Pharmaceuticals Inc. shares retreated slightly in the extended session Tuesday following a big run-up after the biotech company proposed a secondary offering of its shares. Arena shares declined 1.4% to $25.63 after hours, following a 41%...
Forbes  Jul 11  Comment 
Today, after a successful phase 2 trial on a rare lung disease treatment, Arena Pharmaceuticals jumped almost 45% to just under $28. Should investors sell to lock in gains, or hold on? Todd Hagopian is taking profits, selling more than half of his...
Benzinga  Jul 11  Comment 
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) shares are on a roll on Tuesday, rising by about one-half on over 10 times their average volume. The stock is now trading at its highest level in nearly two years. For those keen to the know the reason...
Motley Fool  Jul 11  Comment 
A successful mid-stage trial sent Arena's shares up today.
MarketWatch  Jul 10  Comment 
Arena Pharmaceuticals Inc. shares jumped 35% in late trading Monday after the company announced positive results from a drug study. The San Diego company said that a phase 2 study of a drug targeted at pulmonary arterial hypertension, a disease...
Benzinga  Jul 7  Comment 
With phase 2 results expected to be released in the near future, JMP analyst Jason Butler upgraded his rating on Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) to Market Outperform with a $27 price target. “We believe the stock’s current...
Motley Fool  Jul 6  Comment 
Normally an announcement like this sends a stock's share price lower.





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki